Involvement of nitric oxide and potassium channels in the reduction of basal tone produced by blockade of thromboxane A2/prostaglandin H2 receptors in aortic rings of hypertensive rats

Clinical and Experimental Hypertension

Volumn 20, Issue 8, 1998, Pages 903-916

  DelliPizzi, A ^a   Nasjletti, A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Hypertension; Ifetroban; Nitric oxide; Potassium channels; Smooth muscle tone; Thromboxane A2 prostaglandin H2 receptors

Indexed keywords

IFETROBAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; PROSTAGLANDIN H2; PROSTAGLANDIN RECEPTOR; THROMBOXANE A2 RECEPTOR;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD VESSEL TONE; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; RAT;

EID: 0031765410     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809053254     Document Type: Article

References (12)

1. Pucci ML, Tong X, Miller KB, Guan H, Nasjletti A. Calcium- and protein kinase C-dependent basal tone in the aorta of hypertensive rats. Hypertension 1995;25:752-757.
2. DelliPizzi A, Pucci ML, Mosny AY, DeSeyn K, Nasjletti A. Contribution of constrictor prostanoids to the calcium-dependent basal tone in the aorta from rats with aortic coarctation-induced hypertension: Relationship to nitric oxide. J Pharmacol Exp Ther 1997;283.75-81.
3. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368:850-853.
4. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 1994;91:7583-7587.
5. Murphy ME, Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol Lond 1995;486:47-58.
6. Pataricza J, Toth GK, Penke B, Hohn J, Papp JG. Effect of selective inhibition of potassium channels on vasorelaxing response to cromakalim, nitroglycerin and nitric oxide of canine coronary arteries. J Pharm Pharmacol 1995;47:921-925.
7. Li PL, Zou AP, Campbell WB. Regulation of potassium channels in coronary smooth muscle by endothelium-derived vasodilators. Hypertension 1997;31:303-308.
8. Fernandes M, Onesti G, Weder A, et al. Experimental model of severe renal hypertension. J Lab Clin Med 1976;87:561-567.
9. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799-822.
10. Yuan XJ, Tod ML, Rubin LJ, Blaustein MP. NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels. Proc Natl Acad Sci USA 1996;93:10489-10494.
11. Garland JG, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. BrJ Pharmacol 1992;105:429-435.
12. Lin L, Mistry M, Stier CT, Nasjletti A. Role of prostanoids in renin-dependent and -independent hypertension. Hypertension 1991; 17:517-525.